Plasma and brain methamphetamine concentrations in neonatal rats

Neurotoxicology and Teratology

Volumn 23, Issue 1, 2001, Pages 81-88

  Cappon, Gregg D ^a   Vorhees, Charles V ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Brain methamphetamine concentrations; Methamphetamine; Neonatal rats; Plasma methamphetamine concentrations; Sprague Dawley rats

Indexed keywords

METHAMPHETAMINE;

AGE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BEHAVIOR DISORDER; BLOOD LEVEL; BRAIN LEVEL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LEARNING DISORDER; LEARNING TEST; MALE; MAZE TEST; NEUROTOXICITY; NEWBORN; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; STARTLE REFLEX;

ANIMALS; ANIMALS, NEWBORN; AREA UNDER CURVE; BRAIN; INJECTIONS, SUBCUTANEOUS; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035077283     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(00)00118-5     Document Type: Article

References (48)

1. Stage-specific effects of prenatal D-methamphetamine exposure on behavioral and eye development in rats
2. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat
3. Further studies of the role of hyperthermia in methamphetamine neurotoxicity
4. Methamphetamine and amphetamine neurotoxicity
5. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum
6. Ontogeny of neurotransmitters: Monoamines
7. Disposition and pharmacodynamics of methamphetamine in pregnant sheep
8. 14C]methamphetamine in man, the Guinea pig and the rat
9. α-phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia
10. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response
11. Ice: A new dosage form of an old drug
12. Pharmacokinetics of methamphetamine self-administration to human subjects by smoking S-(+)-methamphetamine hydrochloride
13. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans
14. 3-S-methamphetamine in humans before and after 13 days of oral dosing with S-methamphetamine hydrocloride
15. Methamphetamine: Stimulant of the 1990s?
16. Effects of transplacental exposure to cocaine and methamphetamine on the neonate
17. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates
18. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity
19. Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: Immunohistochemical studies
20. Neurochemistry of amphetamine
21. Methamphetamine abuse during pregnancy: Outcome and fetal effects
22. Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine
23. The interactions of MK-801 with the amphetamine analogues D-methamphetamine, D-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): Neural damage and neural protection
24. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse
25. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine
26. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse
27. Neurotoxic effects of substituted amphetamines in rats and mice: Challenges to the current dogma
28. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates
29. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum
30. Selective neuro-degenerative changes in the rat somatosensory cortex following treatment with methylamphetamine, p-chloroamphetamine but not 6-hydroxydopamine
31. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models
32. Distribution and excretion of methamphetamine and its metabolites in rats: II. Time-course of concentration in blood and distribution after multiple oral administration
33. Distribution and excretion of methamphetamine and its metabolites in rats: III. Time-course of concentrations in blood and bile, and distribution after intravenous administration
34. Neurotoxicity of methamphetamine and related drugs
35. Amphetamine: Efects on catecholamine systems and behavior
36. Chronopharmacokinetics and chronopharmacodynamics of distromethamphetamine in man
37. Treatment of mice with methaphetamine produces cell loss in the substantia nigra
38. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity
39. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice
40. Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux
41. Methamphetamine exposure during early postnatal development in rats: I. Acoustic startle augmentation and spatial learning deficits
42. Methamphetamine exposure during early postnatal development in rats: II. Hypoactivity and altered responses to pharmacological challenge
43. Adult learning deficits after neonatal exposure to D-methamphetamine: Selective effects on spatial navigation and memory
44. Genetic differences in spatial learning between dark agouti and Sprague-Dawley strains: Possible correlation with CYP2D2 polymorphism in rats treated neonatally with methamphetamine
45. CYP2D1 polymorphism in methamphetamine-treated rats: Genetic differences in neonatal mortality and a comparison of spatial learning and acoustic startle
46. Neonatal methamphetamine-induced long-term startle facilitation in rats as a function of prepulse stimulus intensity
47. Neurochemical consequences following administration of CNS stimulants to the neonatal rat
48. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine